The global Animal Growth Promoters & Performance Enhancersmarket was valued at USD 7.90billion in 2016 and is projected to reach USD 12.20billionby 2025, growing at a CAGR of 4.95% from 2017 to 2025.
With increasing animal breeding practices and high demand of meat products and other animal obtained material, the performance enhancer market is expected to grow at a high CAGR.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Incessant Rise in the Global Meat Demand
1.2 Research Studies to Find Alternatives to Antibiotics and Hormones Used as Growth Promoters
1.3 Rise in Animal Epidemic Outbreaks
1.4 Growth Promoters: A Strategic Solution to Rising Animal Feed Costs
2. Market Restraints
2.1 Stringent Regulatory Guidelines in Few Countries
2.2 Increase in Bacterial Resistance Owing to the Use of Antibiotic Growth Promoters
Market Segmentation:
1. By Animal Type:
1.1 Poultry
1.2 Porcine
1.3 Livestock
1.4 Equine
1.5 Aquaculture
1.6 Other Animals
2. By Product:
2.1 Antibiotic Growth Promoters
2.2 Hormonal Growth Promoters
2.3 Beta-Agonist Growth Promoters
2.4 Feed Enzyme Growth Promoter
2.5 Probiotic and Prebiotic Growth Promoters
2.6 Organic Acid Growth Promoters
2.7 Phytogenics
2.8 Other Growth Promoters
3. By Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Cargill, Inc.
2. Royal DSM N.V.
3. Zoetis, Inc.
4. Alltech, Inc.
5. Elanco Animal Health
6. Merck Animal Health
7. AB Vista
8. Bayer Animal Health (A Subsidiary of Bayer AG)
9. Biomin Holding GmbH
10. BoehringerIngelheim
11. Bupo Animal Health
12. Chr. Hansen A/S
13. Danisco A/S
14. Novus International, Inc.
15. Vetoquinol
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Animal Growth Promoters & Performance Enhancersmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE
5.1 Poultry
5.2 Porcine
5.3 Livestock
5.4 Equine
5.5 Aquaculture
5.6 Other Animals
6 GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET, BY PRODUCT
6.1 Antibiotic Growth Promoters
6.2 Hormonal Growth Promoters
6.3 Beta-Agonist Growth Promoters
6.4 Feed Enzyme Growth Promoter
6.5 Probiotic and Prebiotic Growth Promoters
6.6 Organic Acid Growth Promoters
6.7 Phytogenics
6.8 Other Growth Promoters
7 GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERSMARKET, BY GEOGRAPHY
7.1 Overview
7.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
7.5.1 Brazil
7.5.2 Argentina
7.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
8 GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERSMARKETCOMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies
9 COMPANY PROFILES
9.1 Cargill, Inc.
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Royal DSM N.V.
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Zoetis, Inc.
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Alltech, Inc.
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Elanco Animal Health
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Merck Animal Health
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 AB Vista
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 Bayer Animal Health (A Subsidiary of Bayer AG)
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Biomin Holding GmbH
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Development
9.10 BoehringerIngelheim
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Development
9.11 Bupo Animal Health
9.11.1 Overview
9.11.2 Financial Performance
9.11.3 Product Outlook
9.11.4 Key Development
9.12 Chr. Hansen A/S
9.12.1 Overview
9.12.2 Financial Performance
9.12.3 Product Outlook
9.12.4 Key Development
9.13 Danisco A/S
9.13.1 Overview
9.13.2 Financial Performance
9.13.3 Product Outlook
9.13.4 Key Development
9.14 Novus International, Inc.
9.14.1 Overview
9.14.2 Financial Performance
9.14.3 Product Outlook
9.14.4 Key Development
9.15 Vetoquinol
9.15.1 Overview
9.15.2 Financial Performance
9.15.3 Product Outlook
9.15.4 Key Development
10 Appendix
10.1 Related Reports
Price : US$ 3500 |
Date : Dec 2024 |
Category : Telecom and IT |
Pages : 131 |